Abstract
Use of a gonadotropin-releasing hormone (GnRH) antagonist protocol with GnRH agonist (GnRHa) trigger for final oocyte maturation is the most effective strategy to reduce the rate of ovarian hyperstimulation syndrome (OHSS) during IVF. However, concerns persist regarding GnRHa trigger and ART outcomes. Use of a combination GnRHa and low-dose human chorionic gonadotropin (hCG) co-trigger has been reported to reduce OHSS and preserve IVF outcomes. The objective of this study was to examine the impact of final oocyte maturation method (GnRHa v co-trigger) on OHSS, oocyte yield and maturity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
